EUVIMEDEUVIMED entdecken
Fallbericht

Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency

Amnon Zung iD, Niklas Sonntag, Ulrich Schweizer, Ehud Banne, Doreen Braun

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae146 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Amnon Zung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology Unit, Kaplan Medical Center, Rehovot 76100, Israel. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Phenylbutyrates, Symporters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: The Sherman Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Monocarboxylate transporter 8 (MCT8) deficiency is a rare genetic disease that leads to severe global developmental delay. MCT8 facilitates thyroid hormone (TH) transport across the cell membrane, and the serum TH profile is characterized by high T3 and low T4 levels. Recent studies have shown that the chemical chaperone sodium phenylbutyrate (NaPB) restored mutant MCT8 function and increased TH content in patient-derived induced pluripotent stem cells, making it a potential treatment for MCT8 deficiency.

Objective

We aimed to assess the efficacy and safety of glycerol phenylbutyrate (GPB) in MCT8 deficiency.

Methods

We treated 2 monozygotic twins aged 14.5 years with MCT8 deficiency due to P321L mutation with escalating doses of GPB over 13 months. We recorded TH, vital signs, anthropometric measurements, and neurocognitive functions. Resting metabolic rate (RMR) was measured by indirect calorimetry. Serum metabolites of GPB were monitored as a safety measure. In vitro effects of NaPB were evaluated in MDCK1 cells stably expressing the MCT8P321L mutation. The effects of GPB were compared to the effects of DITPA and TRIAC, thyromimetic medications that the patients had received in the past.

Results

NaPB restored mutant MCT8 expression in MDCK1 cells and increased T3 transport into cells carrying the P321L mutation. GPB treatment reduced high T3 and increased low T4 levels. The patients showed a significant weight gain simultaneously with a reduction in RMR. Only minor neurocognitive improvement was observed, in hyperreflexia score and in cognitive functions. Serum metabolites did not exceed the toxic range, but elevated liver transaminases were observed.

Conclusion

In the first report of GPB treatment in MCT8 deficiency we found an improvement in TH profile and body mass index, with minor neurodevelopmental changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monocarboxylic Acid TransportersPhenylbutyratesSymportersHumansAdolescentMaleMuscle HypotoniaAnimalsFemaleX-Linked Intellectual DisabilityTreatment OutcomeMutationMuscular Atrophy

Stichwörter der Autor:innen

3,5-diiodothyropropionic acid (DITPA)glycerol phenylbutyratemonocarboxylate transporter 8peripheral hyperthyroidismresting metabolic ratetriiodothyroacetic acid (TRIAC)

Substanzen

Monocarboxylic Acid TransportersPhenylbutyratesSLC16A2 protein, humanSymporters4-phenylbutyric acid

Autor:innen und Institutionen

  • Pediatric Endocrinology Unit, Kaplan Medical Center, Rehovot 76100, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 12000, Israel.
  • Institut für Biochemie und Molekularbiologie, Medizinische Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn 53115, Germany.
  • The Genetic Institute, Edith Wolfson Medical Center, Holon 5822012, Israel.

ORCID-Profile: Amnon Zung

Förderung

  • The Sherman Foundation
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Zung, A., Sonntag, N., Schweizer, U., Banne, E., & Braun, D. (2024). Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae146

Vancouver

Zung A, Sonntag N, Schweizer U, Banne E, Braun D. Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae146

BibTeX
@article{Zung2024,
  author = {Zung, Amnon and Sonntag, Niklas and Schweizer, Ulrich and Banne, Ehud and Braun, Doreen},
  title = {Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae146}
}
Kostenlos starten →